Meeting
2023 ASCO Annual Meeting
Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy.
Authors
Nicole Yeung
Garvan Institute of Medical Research, Sydney, NSW, Australia
Nicole Yeung , Hui-Ming Lin , Hannah Timmins , Tiffany Li , David Goldstein , Michael Friedlander , Michelle L. Harrison , Kate Lynette Mahon , Peter Meikle , Susanna Park , Lisa Horvath
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3031)
DOI
10.1200/JCO.2023.41.16_suppl.3031
Abstract #
3031
Poster Bd #
229
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Cardiometabolic risk comorbidities in exocrine pancreatic insufficiency compared to patients with cancer: A single centered observational retrospective cohort study.
First Author: James Peeples
Poster
2022 ASCO Annual Meeting
Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).
First Author: Meghna S. Trivedi
Poster
2022 ASCO Annual Meeting
Characterization of alpelisib-associated hyperglycemia in metastatic breast cancer.
First Author: Sherry Shen
Poster
2022 ASCO Genitourinary Cancers Symposium
Lipidomic profiling in patients with heavily pretreated castration-resistant prostate cancer.
First Author: Carlo Cattrini